The Effects of Inorganic Nitrate on Cardiac Muscle in Angina

Status Completed

Clinical Trial Summary

Previous studies have shown that interventions which modestly increase blood nitrite_ improve skeletal muscle function on exercise while sparing oxygen, and have been also shown to open up the blood flow during periods of oxygen deprivation. Inorganic nitrate in the diet is absorbed into the bloodstream, concentrated and reduced by bacteria in the mouth to nitrite, which is then absorbed into the bloodstream. .

The purpose of this study is to look at the effects of oral inorganic nitrate supplementation on clinical markers of heart ischaemia and the frequency of angina.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02078921
Study type	Interventional
Source	University of Aberdeen
Contact
Status	Completed
Phase	Phase 2
Start date	October 2012
Completion date	December 2014

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02908776` - MYocardial DAmage AND MIcrobiota STUDY	N/A
Recruiting	`NCT01397994` - Study to Assess Efficacy of Nicorandil+Atenolol vs Atenolol in Treatment of Chronic Stable Angina.	Phase 4
Active, not recruiting	`NCT00350922` - A Clinical Trial of a Self-Management Education Program for People With Chronic Stable Angina	Phase 1
Completed	`NCT02591758` - Novel Vitality Indices Derived From the Hexoskin in Patients Affected With Angina Undergoing Coronary Revascularization or Medical Therapy
Terminated	`NCT03346278` - Text Message Intervention to Improve Cardiac Rehab Participation	N/A
Active, not recruiting	`NCT06249581` - Pharmacokinetics of AUX-001 40mg Once-daily in Healthy Subjects Under Fasting and Fed Conditions	Early Phase 1
Enrolling by invitation	`NCT03063697` - Observational Study to Evaluate the Safety of DILATREND SR Cap. in Korean Patients With Essential Hypertension, Chronic Stable Angina and Congestive Heart Failure	N/A
Completed	`NCT01239511` - Phase IIb Study of STA-2 in Patients With Chronic Stable Angina	Phase 2
Completed	`NCT02722213` - Mindfulness & Stress Management Study for Cardiac Patients	N/A
Completed	`NCT01484912` - Phase II Study of STA-2 in Patients With Chronic Stable Angina	Phase 2
Recruiting	`NCT03507361` - Myocardial Damage and Music Study	N/A
Recruiting	`NCT03834155` - Enhancing Cardiac Rehabilitation Through Behavioral Nudges	N/A
Active, not recruiting	`NCT02710435` - REDUCER-I: An Observational Study of the Neovasc Reducer™ System
Withdrawn	`NCT00518921` - Capadenoson in Angina Pectoris	Phase 2
Withdrawn	`NCT02423265` - Efficacy of Ranolazine in Patients With Chronic Total Occlusions of Coronary Arteries	Phase 4
Completed	`NCT01369472` - Evaluating Dose-proportionality of Dilatrend Suspended-Release Capsule	Phase 1
Completed	`NCT01340248` - A Randomized, Open-label, Single-dose, Crossover Clinical Trial to Evaluate the Food Effect on the Pharmacokinetics of Dilatrend SR 64mg Capsule After Oral Administration in Healthy Male Volunteers	Phase 1
Completed	`NCT02315001` - Liraglutide to Improve corONary Haemodynamics During Exercise streSS	Phase 2
Completed	`NCT01760083` - A Randomized Multicentre Trial to Evaluate the Utilization of Revascularization or Optimal Medical Therapy for the Treatment of Chronic Total Coronary Occlusions	N/A
Unknown status	`NCT01558830` - Safety of Amiodarone and Ranolazine Together in Patients With Angina	Phase 4